← Back to Search

Carbon Dioxide Filtration Membrane

Memsorb Filter System for Anesthesia Environmental Impact

N/A

Waitlist Available

Research Sponsored by Western University, Canada

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up duration of general anesthesia (up to 12 hours)

Awards & highlights

Study Summary

This trial will help determine if Memsorb is a more efficient and environmentally-friendly option for CO2 filtration in the anesthesia circuit.

Who is the study for?

This trial is for patients undergoing elective surgery, specifically laparoscopic for one part of the study. They should have a physical status classification of ASA I to III, meaning they range from healthy to having some severe disease but not incapacitated. It's not for those with high intracranial pressure, very severe systemic disease (ASA > IV), emergencies, severe respiratory issues like asthma, pregnant individuals or surgeries using regional anesthesia.Check my eligibility

What is being tested?

The trial is testing Memsorb, a new CO2 membrane filter system against traditional chemical granulate absorbers (CGAs) used during anesthesia in surgeries. The goal is to see if Memsorb can effectively remove CO2 and maintain proper ventilation while reducing anesthetic gas use and environmental impact compared to CGAs.See study design

What are the potential side effects?

While specific side effects are not listed for this device trial, potential risks may include inadequate removal of CO2 leading to hypercarbia or insufficient anesthetic delivery; however these will be monitored closely during the study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ duration of general anesthesia (up to 12 hours)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~duration of general anesthesia (up to 12 hours)

This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of general anesthesia (up to 12 hours) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Effectiveness of Memsorb compared to CGA to eliminate CO2

Effectiveness of using Memsorb during ventilation for removal of CO2 in laparoscopic surgeries resulting in high CO2 exposure, compared to CGAs

Anesthesia procedures

Secondary outcome measures

Amount of inhaled anesthetics used

Duration of anesthesia

Freshgas flow during general anesthesia

+3 more

Trial Design

6Treatment groups

Experimental Treatment

Active Control

Group I: Memsorb low-flowExperimental Treatment1 Intervention

Memsorb Filter will be used during low flow general anesthesia (GA)

Group II: Memsorb laparoscopic surgeryExperimental Treatment1 Intervention

Memsorb Filter will be used during general anesthesia for laparoscopic surgery

Group III: Memsorb GAExperimental Treatment1 Intervention

Memsorb Filter will be used during general anesthesia (GA), fresh gas flow and ventilator settings are not modified

Group IV: CGA low flowExperimental Treatment1 Intervention

Chemical CO2 absorber (CGA) will be used during low flow general anesthesia (GA)

Group V: CGA laparoscopic surgeryExperimental Treatment1 Intervention

Chemical CO2 absorber (CGA) will be used during laparoscopic surgery

Group VI: CGA GAActive Control1 Intervention

Chemical CO2 absorber (CGA) will be used during general anesthesia (GA), fresh gas flow and ventilator settings are not modified

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Western University, CanadaLead Sponsor

239 Previous Clinical Trials

56,973 Total Patients Enrolled

Media Library

Memsorb (Carbon Dioxide Filtration Membrane) Clinical Trial Eligibility Overview. Trial Name: NCT04210570 — N/A

Anesthesia Research Study Groups: CGA laparoscopic surgery, CGA low flow, Memsorb laparoscopic surgery, CGA GA, Memsorb GA, Memsorb low-flow

Anesthesia Clinical Trial 2023: Memsorb Highlights & Side Effects. Trial Name: NCT04210570 — N/A

Memsorb (Carbon Dioxide Filtration Membrane) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04210570 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are currently engaged in the experiment?

"Indeed, clinicaltrials.gov attests to the fact that this examination is currently enrolling participants. It was published on March 1st 2021 and modified at the same time, hoping to recruit 510 patients from one medical site."

Answered by AI

Does this experiment require any additional subjects to participate?

"Affirmative. As per the clinicaltrials.gov database, this medical trial is still open to recruitment and was last modified on March 1st 2021 since its initial posting of the same date in 2021."

Answered by AI

What goals is the clinical trial attempting to reach?

"This clinical trial evaluates the efficacy of Memsorb versus CGA to reduce carbon dioxide levels. Moreover, secondary outcomes such as duration of anesthesia (minutes), fresh gas flow during general anesthetic (ml/min) and canisters used over the study period (absolute number) are also assessed over a 12-hour timeframe."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Decreasing Environmental Impact and Costs of Using Inhalational Anesthetic With a Carbon Dioxide Membrane Filter System

2021. "Decreasing Environmental Impact and Costs of Using Inhalational Anesthetic With a Carbon Dioxide Membrane Filter System". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04210570.